RXO INC RXO
19.79
(0.14)
(0.70%)
as of 25 Sep
- Market cap
- $3.3B
- P/E
- 0.0×
Follow RXO
Insider Buys
alert about insiders buying in the last 12 month
| Older periods | Sep '25 | Dec '25 | Mar '26 | Jun '26 | |
|---|---|---|---|---|---|
|
+8 more TTM periods Free account |
(4.89%) | (6.34%) | (6.78%) | (6.79%) | |
| (2.40%) | (2.99%) | (3.20%) | (3.15%) | ||
ROIC |
(2.59%) | (3.34%) | (3.46%) | (2.39%) | |
Return on Tangible Assets |
(18.33%) | (24.21%) | (25.12%) | (23.08%) | |
Average Days of Receivables |
67.84 | 77.93 | 77.41 | 86.56 | |
Free Cash Flow per Share |
(0.10) | (0.04) | (0.08) | (0.44) | |
Free Cash Flow |
(17.00) | (6.00) | (13.00) | (75.00) | |
Capital Expenditures |
(54.00) | (57.00) | (59.00) | (58.00) | |
Piotroski F-Score |
4.00 | 4.00 | 3.00 | 2.00 | |
| Other line items | |||||
Cash ROIC |
1.84% | 2.60% | 2.33% | (0.84%) | |
Accounts Receivable Turnover |
5.30 | 4.68 | 4.85 | 4.85 | |
Accounts Payable Turnover |
9.42 | 8.67 | 8.91 | 8.83 | |
Inventory Turnover |
0.00 | 0.00 | 0.00 | 0.00 | |
Average Days of Payables |
35.41 | 40.98 | 44.21 | 50.23 | |
Days of Inventory on Hand |
0.00 | 0.00 | 0.00 | 0.00 | |
Tax Rate |
(0.19) | (0.13) | (0.16) | (0.15) | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
14.31% | 14.49% | 14.28% | 13.40% | |
Share Based Compensation of Revenue |
0.47% | 0.51% | 0.51% | 0.48% | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF/Net income |
(0.47) | (0.51) | (0.44) | 0.16 | |
Depreciation/Fixed assets |
0.88 | 0.87 | 0.84 | 0.84 | |
Capex/Depreciation |
(0.45) | (0.49) | (0.54) | (0.55) | |
Revenue per Share |
35.24 | 34.08 | 33.91 | 35.89 | |
Operating CF per Share |
0.22 | 0.30 | 0.27 | (0.10) | |
Capex per Share |
(0.32) | (0.34) | (0.35) | (0.34) | |
Capex to Sales |
0.01 | 0.01 | 0.01 | 0.01 | |
Net Profit Margin |
(1.33%) | (1.74%) | (1.83%) | (1.72%) |
Columns are period end dates